Open-label Phase 1 Multiple Dose Escalation Trial to Assess the Safety, Tolerability, and Efficacy of Capsules Containing Cross-linked Polyelectrolyte (CLP) Given to Normal Healthy Volunteers
Latest Information Update: 14 Jan 2020
At a glance
- Drugs Talinexomer (Primary)
- Indications Heart failure
- Focus Pharmacodynamics
- 24 Sep 2013 New trial record